openPR Logo
Press release

Cancer Vaccines Competitive Landscape and Drugs Analysis Report, 2023: FDA Approvals, Clinical Trials, Therapies, MOA, ROA by DelveInsight | Vaccitech, BrightPath Biotherapeutics, Hangzhou Neoantigen Therapeutics, Transgene, Enterome, Amal Therapeutics, O

05-15-2024 08:43 PM CET | Health & Medicine

Press release from: DelveInsight Business Research

Cancer Vaccines Competitive Landscape and Drugs Analysis

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Cancer Vaccines pipeline constitutes 250+ key companies continuously working towards developing 300+ Cancer Vaccines treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.

"Cancer Vaccines Competitive landscape, 2023" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Cancer Vaccines Market.

The Cancer Vaccines Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.

Some of the key takeaways from the Cancer Vaccines Pipeline Report: https://www.delveinsight.com/sample-request/cancer-vaccines-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
• Companies across the globe are diligently working toward developing novel Cancer Vaccines treatment therapies with a considerable amount of success over the years.
• Cancer Vaccines companies working in the treatment market are Vaccitech, BrightPath Biotherapeutics, Hangzhou Neoantigen Therapeutics, Transgene, Enterome, Amal Therapeutics, OncoPep, Inc., Moderna Therapeutics, Gradalis, Inc., IO Biotech, Dendreon Pharmaceutical s LLC, and others, are developing therapies for the Cancer Vaccines treatment
• Emerging Cancer Vaccines therapies in the different phases of clinical trials are- VTP-1100, BP-1209, iNeo-Vac-P01, TG4050, EO2401, ATP128, PVX-410, mRNA-4157, Vigil, IO102-IO103, Sipuleucel-T, and others are expected to have a significant impact on the Cancer Vaccines market in the coming years.
• In December 2023, The mRNA technology utilized in Covid-19 vaccines such as those developed by Pfizer/BioNTech and Moderna (NASDAQ: MRNA) has shown remarkable effectiveness in eliciting an immune response. Drawing on the same mechanism of directing cells to generate particular proteins, scientists are investigating the possibility of mRNA vaccines to activate the immune system against cancer cells.
• In October 2023, BioNTech has administered the initial dose to the first participant in a Phase II clinical study of the cancer vaccine candidate, autogene cevumeran (BNT122, RO7198457), designed to address resected pancreatic ductal adenocarcinoma (PDAC), a form of solid tumor. Autogene cevumeran is an individualized neoantigen-specific immunotherapy (iNeST) candidate based on messenger ribonucleic acid (mRNA).

Cancer Vaccines Overview
Cancer vaccines are a type of immunotherapy designed to stimulate the body's immune system to recognize and attack cancer cells. Unlike traditional vaccines that prevent infectious diseases, cancer vaccines are typically therapeutic, meaning they are used to treat existing cancer rather than to prevent it.

Get a Free Sample PDF Report to know more about Cancer Vaccines Pipeline Therapeutic Assessment-
https://www.delveinsight.com/report-store/cancer-vaccines-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Emerging Cancer Vaccines Drugs Under Different Phases of Clinical Development Include:
• VTP-1100: Vaccitech
• BP-1209: BrightPath Biotherapeutics
• iNeo-Vac-P01: Hangzhou Neoantigen Therapeutics
• TG4050: Transgene
• EO2401: Enterome
• ATP128: Amal Therapeutics
• PVX-410: OncoPep, Inc.
• mRNA-4157: Moderna Therapeutics
• Vigil: Gradalis, Inc.
• IO102-IO103: IO Biotech
• Sipuleucel-T: Dendreon Pharmaceutical s LLC

Cancer Vaccines Pipeline Therapeutics Assessment
• Cancer Vaccines Assessment by Product Type
• Cancer Vaccines By Stage and Product Type
• Cancer Vaccines Assessment by Route of Administration
• Cancer Vaccines By Stage and Route of Administration
• Cancer Vaccines Assessment by Molecule Type
• Cancer Vaccines by Stage and Molecule Type

DelveInsight's Cancer Vaccines Report covers around 300+ products under different phases of clinical development like
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
• Route of Administration

Further Cancer Vaccines product details are provided in the report. Download the Cancer Vaccines pipeline report to learn more about the emerging Cancer Vaccines therapies at:
https://www.delveinsight.com/sample-request/cancer-vaccines-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Some of the key companies in the Cancer Vaccines Therapeutics Market include:
Key companies developing therapies for Cancer Vaccines are - GlaxoSmithKline PLC, Merck & Co. Inc., OSE Immunotherapeutics, Sanofi SA, Dendreon Pharmaceuticals LLC, Moderna Inc., Vaccitech Limited, Anixa Biosciences Inc., AstraZeneca PLC, Bristol Myers Squibb Company, F Hoffmann-La Roche AG (Genentech), Providence Therapeutics, eTheRNA immunotherapies, and others.

Cancer Vaccines Pipeline Analysis:
The Cancer Vaccines pipeline report provides insights into
• The report provides detailed insights about companies that are developing therapies for the treatment of Cancer Vaccines with aggregate therapies developed by each company for the same.
• It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Cancer Vaccines Treatment.
• Cancer Vaccines key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• Cancer Vaccines Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Cancer Vaccines market.
The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.

Download Sample PDF Report to know more about Cancer Vaccines drugs and therapies-
https://www.delveinsight.com/sample-request/cancer-vaccines-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Cancer Vaccines Pipeline Market Drivers
• Clinical trial data using personalized cancer vaccines are highly encouraging, cancer vaccines offer clinical benefits to patients with advanced metastatic disease, an attractive approach to synergize with currently available immune therapeutics strategies are some of the important factors that are fueling the Cancer Vaccines Market.

Cancer Vaccines Pipeline Market Barriers
• However, hurdles in developing appropriate methods to identify, refine and test candidate therapies, high cost associated with the research and other factors are creating obstacles in the Cancer Vaccines Market growth.

Scope of Cancer Vaccines Pipeline Drug Insight
• Coverage: Global
• Key Cancer Vaccines Companies: Vaccitech, BrightPath Biotherapeutics, Hangzhou Neoantigen Therapeutics, Transgene, Enterome, Amal Therapeutics, OncoPep, Inc., Moderna Therapeutics, Gradalis, Inc., IO Biotech, Dendreon Pharmaceutical s LLC, and others
• Key Cancer Vaccines Therapies: VTP-1100, BP-1209, iNeo-Vac-P01, TG4050, EO2401, ATP128, PVX-410, mRNA-4157, Vigil, IO102-IO103, Sipuleucel-T, and others
• Cancer Vaccines Therapeutic Assessment: Cancer Vaccines current marketed and Cancer Vaccines emerging therapies
• Cancer Vaccines Market Dynamics: Cancer Vaccines market drivers and Cancer Vaccines market barriers

Request for Sample PDF Report for Cancer Vaccines Pipeline Assessment and clinical trials-
https://www.delveinsight.com/sample-request/cancer-vaccines-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Table of Contents
1. Cancer Vaccines Report Introduction
2. Cancer Vaccines Executive Summary
3. Cancer Vaccines Overview
4. Cancer Vaccines- Analytical Perspective In-depth Commercial Assessment
5. Cancer Vaccines Pipeline Therapeutics
6. Cancer Vaccines Late Stage Products (Phase II/III)
7. Cancer Vaccines Mid Stage Products (Phase II)
8. Cancer Vaccines Early Stage Products (Phase I)
9. Cancer Vaccines Preclinical Stage Products
10. Cancer Vaccines Therapeutics Assessment
11. Cancer Vaccines Inactive Products
12. Company-University Collaborations (Licensing/Partnering) Analysis
13. Cancer Vaccines Key Companies
14. Cancer Vaccines Key Products
15. Cancer Vaccines Unmet Needs
16 . Cancer Vaccines Market Drivers and Barriers
17. Cancer Vaccines Future Perspectives and Conclusion
18. Cancer Vaccines Analyst Views
19. Appendix
20. About DelveInsight

Related Reports:

Cancer Vaccines Market https://www.delveinsight.com/report-store/cancer-vaccines-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Cancer Vaccines Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-depth understanding of the 7MM, historical and forecasted epidemiology as well as the 7MM market trends in the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom),

Latest Reports:

Aneurysmal Subarachnoid Hemorrhage Market https://www.delveinsight.com/report-store/aneurysmal-subarachnoid-hemorrhage-sah-market
DelveInsight's "Aneurysmal Subarachnoid Hemorrhage (SAH) Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Aneurysmal Subarachnoid Hemorrhage (SAH), historical and forecasted epidemiology as well as the Aneurysmal Subarachnoid Hemorrhage (SAH) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Angelman Syndrome Market https://www.delveinsight.com/report-store/angelman-syndrome-market-forecast
DelveInsight's "Angelman Syndrome Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Angelman Syndrome, historical and forecasted epidemiology as well as the Angelman Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.

Autoimmune Pulmonary Alveolar Proteinosis Market https://www.delveinsight.com/report-store/autoimmune-pulmonary-alveolar-proteinosis-apap-market
DelveInsight's "Autoimmune Pulmonary Alveolar Proteinosis (aPAP) Market Insights, Epidemiology and Market Forecast - 2032" report delivers an in-depth understanding of Autoimmune pulmonary alveolar proteinosis, historical and forecasted epidemiology as well as Autoimmune pulmonary alveolar proteinosis market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan.

Cardiovascular Calcification Market https://www.delveinsight.com/report-store/cardiovascular-calcification-market
DelveInsight's "Cardiovascular Calcification Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Cardiovascular Calcification, historical and forecasted epidemiology as well as the Cardiovascular Calcification market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Charcot Marie Tooth Disease Market https://www.delveinsight.com/report-store/charcot-marie-tooth-disease-market
DelveInsight's 'Charcot-Marie-Tooth Disease Market Insights, Epidemiology, and Market Forecast 2032' report deliver an in-depth understanding of the Charcot-Marie-Tooth Disease, historical and forecasted epidemiology as well as the Charcot-Marie-Tooth Disease market trends in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom) and Japan.

Contact Us:
Gaurav Bora
gbora@delveinsight.com
+14699457679
Healthcare Consulting
https://www.delveinsight.com/consulting-services

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cancer Vaccines Competitive Landscape and Drugs Analysis Report, 2023: FDA Approvals, Clinical Trials, Therapies, MOA, ROA by DelveInsight | Vaccitech, BrightPath Biotherapeutics, Hangzhou Neoantigen Therapeutics, Transgene, Enterome, Amal Therapeutics, O here

News-ID: 3498138 • Views:

More Releases from DelveInsight Business Research

Alzheimer's Disease Pipeline Drugs Analysis Report (2024 Updates): FDA Approvals, Clinical Trials, Therapies, Mechanism of Action, Route of Administration by DelveInsight | Neurodon, Sangamo Therapeutics, NKGen Biotech, Asceneuron, TrueBinding, Alector, C
Alzheimer's Disease Pipeline Drugs Analysis Report (2024 Updates): FDA Approvals …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Alzheimer's Disease pipeline constitutes 150+ key companies continuously working towards developing 160+ Alzheimer's Disease treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. "Alzheimer's Disease Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Alzheimer's Disease Market. The Alzheimer's
Cognitive Impairment Associated with Schizophrenia Pipeline Drugs Analysis Report (2024 Updates): FDA Approvals, Clinical Trials, Therapies, Mechanism of Action, Route of Administration by DelveInsight | Cyclerion Therapeutics, Biogen, Neurocrine Bioscien
Cognitive Impairment Associated with Schizophrenia Pipeline Drugs Analysis Repor …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Cognitive Impairment Associated with Schizophrenia pipeline constitutes 5+ key companies continuously working towards developing 5+ Cognitive Impairment Associated with Schizophrenia treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. "Cognitive Impairment Associated with Schizophrenia Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and
Myotonic Dystrophy Pipeline Drugs Analysis Report, 2024 Updates: FDA Approvals, Clinical Trials, Therapies, MOA, ROA by DelveInsight | Dyne Therapeutics, Avidity Biosciences, Harmony Biosciences, AMO Pharma, Lupin, AMO Pharma
Myotonic Dystrophy Pipeline Drugs Analysis Report, 2024 Updates: FDA Approvals, …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Myotonic Dystrophy pipeline constitutes 20+ key companies continuously working towards developing 22+ Myotonic Dystrophy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. "Myotonic Dystrophy Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Myotonic Dystrophy Market. The Myotonic
Treg Cell-Based Therapies Pipeline Analysis, 2024 Updates | Latest FDA, EMA, and PMDA Approvals | Rapa Therapeutics, Orca Bio, Caladrius Biosciences, Sangamo Therapeutics, Quell Therapeutics, Coya Therapeutics, Sonoma Biotherapeutics, GentiBio, AstraZenec
Treg Cell-Based Therapies Pipeline Analysis, 2024 Updates | Latest FDA, EMA, and …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Treg Cell-Based Therapies pipeline constitutes key companies continuously working towards developing Treg Cell-Based Therapies treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Treg Cell-Based Therapies Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also

All 5 Releases


More Releases for Cancer

Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose. Increase in incidence of target diseases like cancer is key driving factor which is expected to boost
Oncology Nutrition Market led to an unprecedented rise by 2025 : liver cancer, p …
Global Oncology Nutrition Market: Overview Cancer diagnosis creates myriad questions about diet and nutrition. Those pertain to if the food will make a patient feel sick to what should be ingested to fight cancer. This has spawned the oncology nutrition market which has been rising steadily due to the increasing cases of different types of cancer worldwide. During cancer treatment one needs to eat right in order to build up strength
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business. Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports. This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top